← Back to Search

Behavioral Intervention

Smiling instead of Smoking - HIV for Smoking Cessation

N/A
Recruiting
Led By Bettina Hoeppner, PhD, MS
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline and week 20 (3 months after end of treatment)
Awards & highlights

Study Summary

This trial will test a new app-based smoking cessation treatment called SiS-H for people with HIV who smoke. Participants will be compared to those using the National Cancer Institute's app "QuitGuide".

Who is the study for?
This trial is for adults over 18 who are HIV positive, smoke at least weekly, and have smoked more than 100 cigarettes in their lifetime. Participants must be receiving regular HIV care and willing to attempt quitting smoking as part of the study. They also need to allow access to their medical records and app usage data.Check my eligibility
What is being tested?
The trial is testing 'SiS-H,' an integrated mobile health app designed for smoking cessation in people with HIV, against the National Cancer Institute's 'QuitGuide' app. It aims to assess how feasible, acceptable, and effective SiS-H is compared to QuitGuide through a pilot randomized controlled trial.See study design
What are the potential side effects?
Since this trial involves using smartphone apps for smoking cessation rather than medication or medical procedures, there are no direct side effects from interventions like you would expect with drugs or surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline and week 20 (3 months after end of treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline and week 20 (3 months after end of treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
App usage
Secondary outcome measures
App usability rating, System Usability Scale (SUS)
Attitudes Towards Smoking Scale (ATS) - adverse effects of smoking sub-scale
Attitudes Towards Smoking Scale (ATS) - pleasure of smoking sub-scale
+13 more
Other outcome measures
30-day point prevalence abstinence (PPA) - biochemically verified
30-day point prevalence abstinence (PPA) - self-reported
HIV Medication Adherence

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smiling instead of Smoking - HIVExperimental Treatment1 Intervention
Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H), and will be asked to use it for 8 weeks while they quit smoking.
Group II: QuitGuideActive Control1 Intervention
Participants will be onboarded to the smartphone app "QuitGuide" (QG), and will be asked to use it for 8 weeks while they quit smoking.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,934 Previous Clinical Trials
13,198,517 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,671 Previous Clinical Trials
40,926,705 Total Patients Enrolled
Bettina Hoeppner, PhD, MSPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new patients currently being accepted for enrollment in this medical study?

"As per information on clinicaltrials.gov, this study is presently in the recruitment phase. The trial was initially shared on 11/7/2023 and last revised on 3/20/2024."

Answered by AI

What is the total number of individuals who are currently enrolled as participants in this medical study?

"Indeed, the details on clinicaltrials.gov indicate an active search for participants in this research study. The trial was initially posted on November 7th, 2023, and most recently revised on March 20th, 2024. A total of 64 candidates are being sought from a single designated site."

Answered by AI
~18 spots leftby Jul 2024